Drug intelligence / Profile preview

autologous umbilical cord blood cells

Development stage
Discontinued
Lead developer
University of Florida
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

Autologous umbilical cord blood (UCB) is an experimental cell therapy developed by the University of Florida for the treatment of newly diagnosed type 1 diabetes mellitus in children. The therapy involves a single intravenous infusion of the patient's own stored umbilical cord blood, which contains a heterogeneous population of cells including hematopoietic stem cells, mesenchymal stem cells, and regulatory T cells (Tregs). The primary therapeutic goal is to modulate the autoimmune response and preserve residual pancreatic beta-cell function and endogenous insulin production. Although early pilot studies (NCT00305344) demonstrated the safety of the procedure, they failed to show significant efficacy in slowing the decline of C-peptide levels compared to standard care, leading to the termination of this specific investigational approach.

Other names
autologous umbilical cord blood transfusionUCB cell therapyautologous cord blood cells

Beyond the preview

Go deeper on autologous umbilical cord blood cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous umbilical cord blood cells.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call